Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

Successful initial 16hr monkey cell line cov-2 test reported results after two weeks. So now we have much more going on.
Current RBL testing: Evaluating time-to-treatment windows as a post-exposure therapeutic (by introducing Brilacidin at 4, 8, and 16 hours post-initial infection, with virus cultures carried forward up to 48 hours); Exploring if Brilacidin has synergistic properties with other small molecules that have antiviral activity. News from the last pr is Grants filed and being filed so multiple grants.